Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
7,617 results
- Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00108628).
- Cognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cognitive Enhancement Through Computerized Training: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Enhancement Through Computerized Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04244032).
- Cognitive Remediation for Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Remediation for Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01393457).
- Cognitive Remediation With D-Cycloserine: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Remediation With D-Cycloserine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01399866).
- Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05860127).
- Cognitive Training for Nicotine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Training for Nicotine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01252966).
- Cognitive Training Trial: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Training Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01133418).
- Cognitive Training With and Without tDCS to Improve Cognition in HIV: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Training With and Without tDCS to Improve Cognition in HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD): Complete Statistical AnalysisIndependent statistical analysis of Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00219349).
- Cognitive-Behavioral Therapy in Veterans With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Cognitive-Behavioral Therapy in Veterans With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00688259).
- COGNUTRIN in Breast Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of COGNUTRIN in Breast Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01823991).
- CogSMART-PDIndependent statistical analysis of Cognitive Rehabilitation for PD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03335150).
- CogXergaming to Promote Physical Activity and Cognitive Function in Frail Older Adults: Complete Statistical AnalysisIndependent statistical analysis of CogXergaming to Promote Physical Activity and Cognitive Function in Frail Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Cold Laser: A Modality to Promote Vulvar Healing and Pain Relief: Complete Statistical AnalysisIndependent statistical analysis of Cold Laser: A Modality to Promote Vulvar Healing and Pain Relief: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ColdPlay2Independent statistical analysis of Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis: Complete Statistical AnalysisIndependent statistical analysis of Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01066364).
- Collaboration Live: Complete Statistical AnalysisIndependent statistical analysis of Collaboration Live: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04243369).
- Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home: Complete Statistical AnalysisIndependent statistical analysis of Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria: Complete Statistical AnalysisIndependent statistical analysis of Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00351273).
- Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer: primary endpoint…
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt’s Lymphoma or Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with…
- Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: primary…
- Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination Immunotherapy in Biochemically Recurrent Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Immunotherapy in Biochemically Recurrent Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03315871).
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax: Complete Statistical AnalysisIndependent statistical analysis of Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01570036).
- Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers: Complete Statistical AnalysisIndependent statistical analysis of Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01121939).
- Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme: Complete Statistical AnalysisIndependent statistical analysis of Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD): Complete Statistical AnalysisIndependent statistical analysis of Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL: Complete Statistical AnalysisIndependent statistical analysis of Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Combination Therapy for Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Combination Therapy for Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00119158).
- Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna: Complete Statistical AnalysisIndependent statistical analysis of Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial): primary endpoint results, effect estimate…
- Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus: Complete Statistical AnalysisIndependent statistical analysis of Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01378377).
- COMBINEIndependent statistical analysis of Menopur Mixed Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01417195).